Finance

Lists
Why is FRX down 2,49%?
Dive Deeper
FRX:TSE
Fennec Pharmaceuticals Inc
14,49 CA$
-2,49%
(-0,37) 1D
13 հոկ, 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for FRX...
Open
14,49 CA$
High
14,49 CA$
Low
14,49 CA$
Mkt. cap
523,39 մլն
Avg. vol.
476,00
Volume
234,00
52-wk high
17,64 CA$
52-wk low
7,59 CA$
EPS
-0,17 CA$
Beta
1,05
Shares outstanding
35,07 մլն
No. of employees
35
Open
14,49 CA$
High
14,49 CA$
Low
14,49 CA$
Mkt. cap
523,39 մլն
Avg. vol.
476,00
Volume
234,00
52-wk high
17,64 CA$
52-wk low
7,59 CA$
EPS
-0,17 CA$
Beta
1,05
Shares outstanding
35,07 մլն
No. of employees
35
News stories
From web sources and news partners
About Fennec Pharmaceuticals Inc
CEO-
Employees35
Founded1996
HeadquartersԴարեմ, Հյուսիսային Կարոլինա, Միացյալ Նահանգներ
Sector-
Last report
11 օգս, 2026 թ.
Fiscal period
Q2 2026
- / 0,02 $
Revenue / Est. (USD)
17,87 մլն / 16,12 մլն
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
12,46 մլն
13,78 մլն
15,11 մլն
17,87 մլն
Cost of goods sold
660,00 հզր
1,76 մլն
570,00 հզր
721,00 հզր
Cost of revenue
660,00 հզր
1,76 մլն
570,00 հզր
721,00 հզր
Research and development expenses
29,00 հզր
20,00 հզր
49,00 հզր
118,00 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,96 մլն
14,55 մլն
14,61 մլն
15,30 մլն
Operating expense
11,99 մլն
14,57 մլն
14,66 մլն
15,42 մլն
Total operating expenses
12,65 մլն
16,33 մլն
15,23 մլն
16,14 մլն
Operating income
-189,00 հզր
-2,55 մլն
-119,00 հզր
1,74 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-638,00 հզր
-4,68 մլն
201,00 հզր
2,02 մլն
EBT excluding unusual items
-638,00 հզր
-2,66 մլն
201,00 հզր
2,02 մլն
Income tax expense
-
106,00 հզր
-
42,00 հզր
Effective tax rate
-
-2,26%
-
2,08%
Other operating expenses
-
-
-
-
Net income
-638,00 հզր
-4,79 մլն
201,00 հզր
1,97 մլն
Net profit margin
-5,12%
-34,75%
1,33%
11,04%
Earnings per share
-0,02
-0,10
-
-
Interest and investment income
152,00 հզր
228,00 հզր
339,00 հզր
287,00 հզր
Interest expense
-598,00 հզր
-334,00 հզր
-7,00 հզր
-3,00 հզր
Net interest expenses
-446,00 հզր
-106,00 հզր
332,00 հզր
284,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-163,00 հզր
-2,53 մլն
-93,00 հզր
1,76 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps